These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Placebo-controlled, comparative study of the efficacy and safety of triamcinolone acetonide inhalation aerosol with the non-CFC propellant HFA-134a in patients with asthma. Azmacort HFA Clinical Study Group. Jacobson K; Chervinsky P; Noonan M; Kane RE; Banerji D; Uryniak T Ann Allergy Asthma Immunol; 1999 Oct; 83(4):327-33. PubMed ID: 10541425 [TBL] [Abstract][Full Text] [Related]
23. Effects on lung function, symptoms, and bronchial hyperreactivity of low-dose inhaled beclomethasone dipropionate given with HFA-134a or CFC propellant. Woodcock A; Williams A; Batty L; Masterson C; Rossetti A; Cantini L J Aerosol Med; 2002; 15(4):407-14. PubMed ID: 12581507 [TBL] [Abstract][Full Text] [Related]
24. Equivalent asthma control after dose reduction with HFA-134a beclomethasone solution aerosol. Comparative Inhaled Steroid Investigation Group (CISIG). Magnussen H Respir Med; 2000 Jun; 94(6):549-55. PubMed ID: 10921758 [TBL] [Abstract][Full Text] [Related]
25. Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma. Farmer IS; Middle M; Savic J; Perri VL; Herdman MJ Respir Med; 2000 Jan; 94(1):57-63. PubMed ID: 10714480 [TBL] [Abstract][Full Text] [Related]
26. Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients. Corren J; Nelson H; Greos LS; Bensch G; Goldstein M; Wu J; Wang S; Newman K Ann Allergy Asthma Immunol; 2001 Nov; 87(5):405-11. PubMed ID: 11730183 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of inhaled ciclesonide compared with chlorofluorocarbon beclomethasone dipropionate in adults with moderate to severe persistent asthma. Adachi M; Ishihara K; Inoue H; Kudo K; Takahashi K; Morita Y; Masuda K; Sakai T; Kato R; Miyamoto T Respirology; 2007 Jul; 12(4):573-80. PubMed ID: 17587425 [TBL] [Abstract][Full Text] [Related]
28. [Influence of changing from chlorofluorocarbon (CFC)-beclomethasone dipropionate (BDP) to hydrofluoroalkane (HFA)-BDP on pulmonary function in asthmatic children]. Yoshida Y; Inoue T; Nishikido T; Kameda M; Takamatu I; Doi S Arerugi; 2007 Dec; 56(12):1502-9. PubMed ID: 18195554 [TBL] [Abstract][Full Text] [Related]
29. Comparison of hydrofluoroalkane-beclomethasone dipropionate Autohaler with budesonide Turbuhaler in asthma control. Worth H; Muir JF; Pieters WR Respiration; 2001; 68(5):517-26. PubMed ID: 11694816 [TBL] [Abstract][Full Text] [Related]
30. Effects of mometasone furoate dry powder inhaler and beclomethasone dipropionate hydrofluoroalkane and chlorofluorocarbon on the hypothalamic-pituitary-adrenal axis in asthmatic subjects. Chrousos GP; Ghaly L; Shedden A; Iezzoni DG; Harris AG Chest; 2005 Jul; 128(1):70-7. PubMed ID: 16002918 [TBL] [Abstract][Full Text] [Related]
31. Both bronchial and alveolar exhaled nitric oxide are reduced with extrafine beclomethasone dipropionate in asthma. Nicolini G; Chetta A; Simonazzi A; Tzani P; Aiello M; Olivieri D Allergy Asthma Proc; 2010; 31(5):85-90. PubMed ID: 20929599 [TBL] [Abstract][Full Text] [Related]
32. Inhaled beclomethasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma. Milanowski J; Qualtrough J; Perrin VL Respir Med; 1999 Apr; 93(4):245-51. PubMed ID: 10464888 [TBL] [Abstract][Full Text] [Related]
33. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study. Wolthers OD; Walters EG Clin Ther; 2011 Aug; 33(8):1069-76. PubMed ID: 21784529 [TBL] [Abstract][Full Text] [Related]
34. Hydrofluoroalkane-134A beclomethasone or chlorofluorocarbon fluticasone: effect on small airways in poorly controlled asthma. Thongngarm T; Silkoff PE; Kossack WS; Nelson HS J Asthma; 2005 May; 42(4):257-63. PubMed ID: 16032934 [TBL] [Abstract][Full Text] [Related]
35. Equivalence of asthma control with new CFC-free formulation HFA-134a beclomethasone dipropionate and CFC-beclomethasone dipropionate. Dahl R; Ringdal N; Ward SM; Stampone P; Donnell D Br J Clin Pract; 1997; 51(1):11-5. PubMed ID: 9158265 [TBL] [Abstract][Full Text] [Related]
36. Beclometasone dipropionate extrafine aerosol versus fluticasone propionate in children with asthma. van Aalderen WM; Price D; De Baets FM; Price J Respir Med; 2007 Jul; 101(7):1585-93. PubMed ID: 17254760 [TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma. Vanden Burgt JA; Busse WW; Martin RJ; Szefler SJ; Donnell D J Allergy Clin Immunol; 2000 Dec; 106(6):1209-26. PubMed ID: 11112914 [TBL] [Abstract][Full Text] [Related]
38. Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma. Reichel W; Dahl R; Ringdal N; Zetterstrom O; van den Elshout FJ; Laitinen LA Int J Clin Pract; 2001 Mar; 55(2):100-6. PubMed ID: 11321849 [TBL] [Abstract][Full Text] [Related]
39. Clinical studies in asthmatics with a new non-extra fine HFA formulation of beclometasone dipropionate (BDP Modulite). Bousquet J; Cantini L Respir Med; 2002 Aug; 96 Suppl D():S17-27. PubMed ID: 12201078 [TBL] [Abstract][Full Text] [Related]
40. Switch to non-CFC inhaled corticosteroids: a comparative efficacy study of HFA-BDP and CFC-BDP metered-dose inhalers. Demedts M; Cohen R; Hawkinson R Int J Clin Pract; 1999; 53(5):331-8. PubMed ID: 10695095 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]